MoneyWorks4Me

Bharat Parenterals - Quaterly Results

22 May 2024 Evaluate
The sales figure stood at Rs. 656.40 millions for the March 2024 quarter. The mentioned figure indicates a growth of about 28.78% as compared to Rs. 509.70 millions during the year-ago period.The Net Profit of the company slipped to Rs. 30.70 millions from Rs. 92.90 millions, a decline of -66.95% on QoQ basis.The company reported a degrowth in operating Profit to 69.80 millions from 135.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 656.40 509.70 28.78 2541.60 2179.80 16.60 2541.60 2179.80 16.60
Other Income 32.40 69.60 -53.45 119.50 188.40 -36.57 119.50 188.40 -36.57
PBIDT 69.80 135.50 -48.49 403.90 402.10 0.45 403.90 402.10 0.45
Interest 10.90 8.00 36.25 31.90 21.90 45.66 31.90 21.90 45.66
PBDT 58.90 127.50 -53.80 372.00 380.20 -2.16 372.00 380.20 -2.16
Depreciation 16.10 14.30 12.59 64.00 58.50 9.40 64.00 58.50 9.40
PBT 42.80 113.20 -62.19 308.00 321.70 -4.26 308.00 321.70 -4.26
TAX 12.10 20.30 -40.39 82.10 78.30 4.85 82.10 78.30 4.85
Deferred Tax -3.90 -7.30 -46.58 -4.50 -5.70 -21.05 -4.50 -5.70 -21.05
PAT 30.70 92.90 -66.95 225.90 243.40 -7.19 225.90 243.40 -7.19
Equity 58.20 57.70 0.87 58.20 57.70 0.87 58.20 57.70 0.87
PBIDTM(%) 10.63 26.58 -60.00 15.89 18.45 -13.85 15.89 18.45 -13.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..